Managing Director & Senior Partner
San Francisco - Bay Area
Dr. Sanjay Saxena is a core member of The Boston Consulting Group’s Health Care practice and the global leader of the payer and provider sector. He is also coleader of BCG's Center for US Health Care Reform and Evolution.
Sanjay has extensive health care consulting and industry experience, specializing in strategy development, transformation, and enablement for payer and provider organizations. He has successfully led more than 100 engagements for hospitals and health systems, academic medical centers, children's hospitals, integrated delivery organizations, national insurers, BlueCross BlueShield plans, and health care services companies.
Over the course of his career, Sanjay has also worked with health segment leaders of consumer, media, and digital companies, as well as with private equity clients investing in health care. His work involves helping senior executives and boards respond to disruptive industry changes, and he has helped design and implement numerous new care models, innovative payment approaches, and cross-sector collaborations.
Sanjay has also been involved in multiple due diligence and postmerger integration efforts across the delivery system. He has published and presented on a wide range of topics, including consumerism, bundled payments, payer-provider collaboration, hospital and health system strategy and M&A, Medicaid, and value-based care.
Sanjay previously served as a medical director at a BlueCross BlueShield plan. He is a member of several professional organizations, including the American Medical Association and the Northwestern University Leadership Circle’s Regional Council.
The actions that health insurers take—or do not take—in the next three to six months will determine their ability to compete and thrive beyond the end of this year.
Public health will be immeasurably harmed if providers and facilities do not begin providing the full portfolio of patient services as soon as local conditions safely allow.
Preparing Localities for Action Against Novel Coronavirus (PLAN) is a scenario-planning tool that identifies potential US supply and demand imbalances down to the county level.
Even with the federal government’s $100 billion stimulus package for the health care industry, US hospitals will still face significant financial pressures due to COVID-19.
Dealing with an outbreak on this scale requires solutions on both the supply and demand side, as BCG experts argue in the journal Health Management and Policy Innovation.
With previously unknown disruptions reshaping the industry, incumbents must build a future-proofed business that can withstand adversity, no matter where it comes from.
Health care payers should approach this huge, high-growth market with eyes wide open.
First determine which business problems are most pressing and then figure out how advanced analytics can best solve them.
As consumers become increasingly active in health care decision making, providers need to understand how they weigh the tradeoffs in cost, quality, provider choice, and other key metrics.